Sienna Biopharmaceuticals, Inc. Skyrocketed
Mon 23 Dec 19 at 05:30 PM
Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ) jumped higher at $0.14, representing a gain of 30.7%. The stock appeared on our News Catalysts scanner on Fri 13 Dec 19 at 12:16 PM in the 'RECOMMENDATION' category. From Mon 02 Dec 19, the stock recorded 28.57% Up Days and 53.33% Green Days
About Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ)
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development and commercialization of targeted, topical products in medical dermatology and aesthetics.
Top 10 Gainers:
- Intra-Cellular Therapies, Inc. (ITCI:NASDAQ), 193.49%
- Liminal BioSciences Inc. (LMNL:NASDAQ), 83.03%
- China Finance Online Co. Limited (JRJC:NASDAQ), 78.35%
- Microbot Medical Inc. (MBOT:NASDAQ), 77.37%
- Cassava Sciences, Inc. (SAVA:NASDAQ), 59.56%
- Seadrill Limited (SDRL:NYSE), 38.46%
- Hexindai Inc. (HX:NASDAQ), 37.3%
- Cincinnati Bell Inc. (CBB:NYSE), 35.36%
- Cabaletta Bio, Inc. (CABA:NASDAQ), 33.86%
- Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ), 30.7%